Creative Biolabs-Immuno-oncology

Anti-DSG2 (clone G1G2E9Q) SynExpress E1-G-L/T-E Modified CD8+ T cells (CAT#: ITS-1224-CR2363)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DSG2 (clone G1G2E9Q). We employs the pGEM (EF1α-GFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Exons RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DSG2
Clone
G1G2E9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.94
Cell Culture
Microcarrier Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.